GENNUX MICROSYSTEMS
Gennux Microsystems has provided two electronic message protection solutions that will provide private, non-threatening security for email and mobile phone users and optimise their return on investment. One service that works in all languages, offers full message and attachment security, and allows business users to manage their email inboxes.
GENNUX MICROSYSTEMS
Industry:
Cyber Security Electronics Security Semiconductor
Founded:
2002-01-01
Address:
Edmonton, Alberta, Canada
Country:
Canada
Website Url:
http://www.gennux.com
Total Employee:
11+
Status:
Active
Contact:
780 437 3806
Total Funding:
0
Similar Organizations
eSecurity Solutions
eSecurity Solutions is a company that offers products and managed security services.
Reece
Reece uses a layered strategy that combines access systems, video surveillance, and fire alarms to provide security management systems.
Investors List
Advanced Technology Centre
Advanced Technology Centre investment in Pre Seed Round - Gennux Microsystems
Official Site Inspections
http://www.gennux.com
- Host name: ewall.pureinbox.com
- IP address: 174.129.242.215
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Gennux Microsystems"
Genelux Corporation - Wikipedia
Genelux Corporation is a publicly traded late clinical-stage company developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Companyโs most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity. See details»
Genelux Corporation | Company
Our vision is to build a pre-eminent immuno-oncology company that addresses serious unmet medical needs. Our mission is to develop immunotherapeutics that deliver the full complement of tumor neo-antigens with the power to stimulate โฆSee details»
Genelux - LinkedIn
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improving the lives of patients affected by difficult-to-treat solid tumors.See details»
Genelux Corporation (GNLX) - Yahoo Finance Canada
See the company profile for Genelux Corporation (GNLX) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Genelux Corporation (GNLX) Company Profile & Overview - Stock โฆ
2625 Townsgate Road, Suite 230 Westlake Village, California 91361 United StatesSee details»
Thomas Zindrick - President, Chief Executive Officer and Chairman ...
President, Chief Executive Officer and Chairman at Genelux Corporation · Accomplished senior executive with diverse experience in life science companies. · Experience: Genelux โฆSee details»
Company Genelux Corporation - MarketScreener.com
Aug 31, 2002 Genelux Corporation is a late clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of next-generation oncolytic viral โฆSee details»
Genelux - VentureRadar
Genelux Corporation is a privately held, biopharmaceutical clinical stage company that was founded in 2001. The main focus of Genelux is oncolytic... ... Find out ...See details»
Genlux Lighting - Crunchbase Company Profile & Funding
Organization. Genlux Lighting . Connect to CRM . Save . Summary. People. Signals & News. About. ... Genlux Lighting is located in Gauteng, NA - South Africa, South Africa. Unlock even โฆSee details»
Genelux Corp, GNLX:NAQ profile - FT.com - Financial Times
Genelux Corporation is a late clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients โฆSee details»
News Releases - Genelux Corporation
Oct 9, 2024 WESTLAKE VILLAGE, Calif. , Nov. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today โฆSee details»
Genelux - Funding, Financials, Valuation & Investors - Crunchbase
Genelux is a biopharmaceutical company that develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.See details»
Genelux - Overview, News & Similar companies | ZoomInfo.com
Nov 17, 2023 View Genelux (www.genelux.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Genelux Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch
2 days ago GNLX | Complete Genelux Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.See details»
Genelux Corporation (GNLX) Stock Price, Quote & News - Stock โฆ
3 days ago About GNLX. Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering โฆSee details»
Genelux Management - Simply Wall St
Genelux's CEO is Tom Zindrick, appointed in May 2014, has a tenure of 10.5 years. total yearly compensation is $6.20M, comprised of 9.2% salary and 90.8% bonuses, including company โฆSee details»
Genelux Corporation (GNLX) - Yahoo Finance Canada
Find the latest Genelux Corporation (GNLX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
art of elysium heaven gala โ GENLUX
This organization was created in 1997 and ultimately gives support to celebrities who desire to give their time and support to these children of need. Through classes designed to infiltrate โฆSee details»
art+fashion+charity calendar โ GENLUX
Calendar of charity events in Los Angeles, New YorkSee details»
How gen AI enables the boundaryless organization | Fortune
2 days ago Gen AI offers companies the opportunity to break down silos that hinder growth.See details»